Connor, Clark & Lunn Investment Management Ltd. Dr Reddys Laboratories LTD Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $18.8 Billion
- Q3 2024
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 155,481 shares of RDY stock, worth $2.18 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
155,481
Previous 48,685
219.36%
Holding current value
$2.18 Million
Previous $3.71 Million
233.03%
% of portfolio
0.07%
Previous 0.02%
Shares
26 transactions
Others Institutions Holding RDY
# of Institutions
250Shares Held
33.5MCall Options Held
12.7KPut Options Held
6.1K-
Robeco Institutional Asset Management B.V.11.4MShares$160 Million0.35% of portfolio
-
Morgan Stanley New York, NY2.24MShares$31.4 Million0.01% of portfolio
-
Royal Bank Of Canada Toronto, A62MShares$28 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.95MShares$27.3 Million0.25% of portfolio
-
Black Rock Inc. New York, NY1.8MShares$25.2 Million0.0% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.33B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...